Cargando…
Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells
Elevated levels of free fatty acids (FFAs) in the liver, resulting from either increased lipolysis or imbalanced FFAs flux, is a key pathogenic factor of hepatic steatosis. This study was conducted to examine the therapeutic effect of tetrahydrocurcumin (THC), a naturally occurring curcuminoid and a...
Autores principales: | Chen, Jin-Wun, Kong, Zwe-Ling, Tsai, Mei-Ling, Lo, Chih-Yu, Ho, Chi-Tang, Lai, Ching-Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303024/ https://www.ncbi.nlm.nih.gov/pubmed/29976400 http://dx.doi.org/10.1016/j.jfda.2018.01.005 |
Ejemplares similares
-
Role of biotransformation in the diazinon-induced toxicity in HepG2 cells and antioxidant protection by tetrahydrocurcumin
por: Miranda, Camila Araújo, et al.
Publicado: (2022) -
Inhibitory Effect of Gardenoside on Free Fatty Acid-Induced Steatosis in HepG2 Hepatocytes
por: Liang, Huiqing, et al.
Publicado: (2015) -
Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism
por: He, Miao, et al.
Publicado: (2020) -
The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin
por: Lai, Ching-Shu, et al.
Publicado: (2020) -
Flavonones from Penthorum chinense Ameliorate Hepatic Steatosis by Activating the SIRT1/AMPK Pathway in HepG2 Cells
por: Guo, Wei-Wei, et al.
Publicado: (2018)